Johns Hopkins Bloomberg School of Public Health, Baltimore, Md.
Yale New Haven Health Bridgeport Hospital, Bridgeport, Conn.
Am J Med. 2024 Dec;137(12):1255-1263.e16. doi: 10.1016/j.amjmed.2024.07.009. Epub 2024 Jul 30.
We sought to evaluate the associations of chest pain and dyspnea with the long-term risk of cardiovascular disease including coronary disease, heart failure, atrial fibrillation, and stroke.
In 13,200 participants without cardiovascular disease in the Atherosclerosis Risk in Communities study (1987-1989), chest pain was categorized into definite angina, possible angina, non-anginal chest pain, and no chest pain using the Rose questionnaire. Dyspnea was categorized into grades 3-4, 2, 1, and 0 by the modified Medical Research Council scale. The associations of chest pain and dyspnea with incident myocardial infarction, heart failure, atrial fibrillation, and stroke over a median follow-up of ∼27 years were quantified with multivariable Cox models.
Definite angina and possible angina were associated with myocardial infarction (adjusted hazard ratios [HR] 1.80 [95%CI 1.45-2.13] and 1.65 [1.27-2.15]). Although lesser magnitude than myocardial infarction, both definite and possible angina were associated with heart failure. For atrial fibrillation, possible angina showed higher HR than definite angina. Dyspnea showed similar HRs for myocardial infarction and heart failure in grades 3-4 (2.00 [1.61-2.49] and 1.94 [1.62-2.32]). Stroke was least associated with chest symptoms. Chest pain and dyspnea significantly improved the discrimination of cardiovascular disease except stroke, beyond traditional risk factors.
In individuals without cardiovascular disease, chest pain and dyspnea were independently associated with incident cardiovascular disease for about 3 decades, suggesting the need for evaluating chest pain from a broader perspective of cardiovascular disease beyond coronary disease and the importance of dyspnea for cardiovascular risk assessment including myocardial infarction.
我们旨在评估胸痛和呼吸困难与包括冠心病、心力衰竭、心房颤动和中风在内的心血管疾病长期风险之间的关联。
在无心血管疾病的 13200 名动脉粥样硬化风险社区研究(1987-1989 年)参与者中,使用 Rose 问卷将胸痛分为明确心绞痛、可能心绞痛、非心绞痛胸痛和无胸痛。呼吸困难采用改良的医学研究委员会量表分为 3-4 级、2 级、1 级和 0 级。通过多变量 Cox 模型定量评估胸痛和呼吸困难与中位随访时间约 27 年的心肌梗死、心力衰竭、心房颤动和中风的发生风险之间的关联。
明确心绞痛和可能心绞痛与心肌梗死相关(校正后的危险比[HR]分别为 1.80[95%CI 1.45-2.13]和 1.65[1.27-2.15])。尽管程度低于心肌梗死,但明确和可能心绞痛均与心力衰竭相关。对于心房颤动,可能心绞痛的 HR 高于明确心绞痛。呼吸困难在 3-4 级时,与心肌梗死和心力衰竭的 HR 相似(2.00[1.61-2.49]和 1.94[1.62-2.32])。中风与胸痛症状的相关性最低。胸痛和呼吸困难显著提高了心血管疾病的区分度,除了中风外,也优于传统危险因素。
在无心血管疾病的个体中,胸痛和呼吸困难与未来 30 年内发生心血管疾病独立相关,这表明需要从心血管疾病的更广泛角度评估胸痛,而不仅仅是冠心病,并且呼吸困难对包括心肌梗死在内的心血管风险评估很重要。